ICOSL aAPC CHO
CBP74490
詢 價(jià)
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| N/A | |
| II. Description | |
| N/A | |
| II. Introduction | |
| Expressed gene: | ICOSL |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+ 3 μg/ml Puromycin+600 μg/ml Hygromycin B |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
 Figure 1. Recombinant ICOSL aAPC CHO stably expressing ICOSL.  Figure 2. Dose Response of ICOS Agonist Abs in ICOS Effector Reporter Cell(C3) with FCGR2B TCR Activitor CHO(C18).
 Figure 3. Blocking of ICOSL induced ICOS Effector Reporter Cell(C3) Activity by ICOSL Blocking Ab with ICOSL aAPC CHO. |
|
